The increasing incidence of blood disorders and the growth in the number of blood donation are the major factors driving the growth of the global hematology analyzers and reagents market. Technological advancements in hematology analyzers and reagents and the integration of flow cytometry techniques with hematology analyzers are also expected to support the growth of this market during the forecast period.
The global hematology analyzers and reagents market size is expected to reach USD 10.6 billion by 2025 from USD 7.6 billion in 2020, at a CAGR of 6.9%.
Download PDF Brochure: – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153222146
Market Drivers:
- Increasing Disease Prevalence: The rising incidence of blood disorders, including anemia, leukemia, and hemophilia, is driving the demand for hematology analyzers and reagents for accurate diagnosis and disease monitoring.
- Aging Population: The aging global population is contributing to the demand for diagnostic tests, as older individuals are more susceptible to blood-related conditions.
- Technological Advancements: Ongoing developments in hematology analyzer technology, such as multi-parameter analysis, flow cytometry, and automation, are improving diagnostic accuracy and efficiency.
- Point-of-Care Testing: The demand for point-of-care hematology analyzers is increasing due to the need for rapid results in emergency situations and resource-limited settings.
- Personalized Medicine: Hematology analyzers play a role in tailoring treatment plans for individual patients based on their blood profiles, contributing to the growth of personalized medicine.
Market Segmentation:
The hematology analyzers and reagents market can be segmented based on product type, application, end-user, and geography.
- Product Type: Automated Hematology Analyzers, Semi-Automated Hematology Analyzers.
- Application: Complete Blood Count (CBC), Coagulation Testing, Hemoglobinopathy Testing, Bone Marrow Analysis, and more.
- End-user: Hospitals, Diagnostic Laboratories, Research Institutions, and Academic Centers.
Regional Analysis:
North America accounted for the largest share of the market in 2019. This can be attributed to the rising incidence of patients suffering from blood disorders, the growing prevalence of target diseases, and the rising demand for blood transfusions in the region.
Recent Developments:
- In February 2018, Sysmex entered into an agreement with McKesson to distribute Sysmex’s XW-100 automated hematology analyzers in the US.
- In September 2017, Sysmex entered into an agreement with Mongolia’s Ministry of Health to provide technological, scientific, and external quality assessment support in the field of blood morphology to raise the accuracy of testing in the Mongolian region.
- Sysmex expanded its direct sales network in the Republic of Ghana (Africa) to reinforce its hematology sales and service structure in the African market.
Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=153222146
Top Key Players: –
The major players in the global hematology analyzers and reagents market are Sysmex Corporation (Japan), Abbott Laboratories (US), Danaher Corporation (US), Nihon Kohden (Japan), Siemens (Germany), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories (US), BioSystems (Spain), Diatron (Hungary), Drew Scientific (US), EKF Diagnostics (UK), Mindray (China), Ortho Clinical Diagnostics (US), and Roche (Switzerland).
The hematology analyzers and reagents market is expected to continue growing due to the increasing demand for accurate and timely diagnostic testing. Advances in technology, automation, and the integration of artificial intelligence are likely to drive innovation in this field. Collaboration between diagnostic companies and healthcare providers will play a significant role in addressing challenges and capitalizing on the opportunities within the hematology analyzers and reagents market.
